
Sagar S. Patel
Examiner (ID: 4191)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626 |
| Total Applications | 643 |
| Issued Applications | 430 |
| Pending Applications | 77 |
| Abandoned Applications | 159 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16436997
[patent_doc_number] => 20200354323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/936725
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936725
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936725 | Syntheses of N-heterocyclic carbenes and intermediates therefor | Jul 22, 2020 | Issued |
Array
(
[id] => 16582912
[patent_doc_number] => 20210017314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => PROTEIN-POLYMER NANOASSEMBLIES AND INTRACELLULAR PROTEIN DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/932774
[patent_app_country] => US
[patent_app_date] => 2020-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16932774
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/932774 | Protein-polymer nanoassemblies and intracellular protein delivery | Jul 18, 2020 | Issued |
Array
(
[id] => 18065472
[patent_doc_number] => 20220396559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => N-((1,2,3.5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-4, 5, 6, 7-TETRAHYDROBENZOFURAN -2-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS NLPR3 MODULATORS FOR THE TREATMENT OF MULTIPLE SCLEROSIS (MS)
[patent_app_type] => utility
[patent_app_number] => 17/627082
[patent_app_country] => US
[patent_app_date] => 2020-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627082 | N-((1,2,3,5,6,7-hexahydro-S-indacen-4-yl)carbamoyl)-4, 5, 6, 7-tetrahydrobenzofuran-2-sulfonamide derivatives and related compounds as NLPR3 modulators for the treatment of multiple sclerosis (MS) | Jul 15, 2020 | Issued |
Array
(
[id] => 18301123
[patent_doc_number] => 11623009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Bone fracture repair by targeting of agents that promote bone healing
[patent_app_type] => utility
[patent_app_number] => 16/927773
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 13027
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16927773
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/927773 | Bone fracture repair by targeting of agents that promote bone healing | Jul 12, 2020 | Issued |
Array
(
[id] => 16657283
[patent_doc_number] => 20210053919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => 5-BROMO-INDIRUBINS
[patent_app_type] => utility
[patent_app_number] => 16/921856
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16921856
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/921856 | 5-Bromo-indirubins | Jul 5, 2020 | Issued |
Array
(
[id] => 20535693
[patent_doc_number] => 12552757
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => NRF2-activating compound
[patent_app_type] => utility
[patent_app_number] => 17/623983
[patent_app_country] => US
[patent_app_date] => 2020-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50122
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623983
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/623983 | NRF2-activating compound | Jul 2, 2020 | Issued |
Array
(
[id] => 16390887
[patent_doc_number] => 20200331828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => NOVEL COMPOUNDS WHICH ACTIVATE ESTROGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/919466
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -73
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16919466
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/919466 | NOVEL COMPOUNDS WHICH ACTIVATE ESTROGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USING THE SAME | Jul 1, 2020 | Abandoned |
Array
(
[id] => 17938385
[patent_doc_number] => 11472826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Acyclic antivirals
[patent_app_type] => utility
[patent_app_number] => 16/916618
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 17
[patent_no_of_words] => 44974
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 433
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16916618
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/916618 | Acyclic antivirals | Jun 29, 2020 | Issued |
Array
(
[id] => 17895322
[patent_doc_number] => 20220304984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/618829
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618829 | AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF | Jun 11, 2020 | Pending |
Array
(
[id] => 17748095
[patent_doc_number] => 20220226298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => GPR40 AGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/614100
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614100 | GPR40 AGONISTS | May 21, 2020 | Abandoned |
Array
(
[id] => 16328305
[patent_doc_number] => 20200299271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => METHOD FOR PRODUCING 5-HYDROXYALKYL-SUBSTITUTED 1-PHENYL-1,2,4- TRIAZOLE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/880933
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16880933
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/880933 | METHOD FOR PRODUCING 5-HYDROXYALKYL-SUBSTITUTED 1-PHENYL-1,2,4- TRIAZOLE DERIVATIVES | May 20, 2020 | Abandoned |
Array
(
[id] => 17556000
[patent_doc_number] => 11312675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol
[patent_app_type] => utility
[patent_app_number] => 15/930193
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13208
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930193
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930193 | Crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol | May 11, 2020 | Issued |
Array
(
[id] => 16238195
[patent_doc_number] => 20200255429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING HETEROATOM-LINKED AROMATIC MOIETIES, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/865009
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16865009
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/865009 | Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor | Apr 30, 2020 | Issued |
Array
(
[id] => 20171717
[patent_doc_number] => 12390437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response
[patent_app_type] => utility
[patent_app_number] => 17/606884
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63488
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 589
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606884 | Itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response | Apr 29, 2020 | Issued |
Array
(
[id] => 16420462
[patent_doc_number] => 20200345660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => Topical Analgesic Gel Compositions
[patent_app_type] => utility
[patent_app_number] => 16/856176
[patent_app_country] => US
[patent_app_date] => 2020-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16856176
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/856176 | Topical analgesic gel compositions | Apr 22, 2020 | Issued |
Array
(
[id] => 17911261
[patent_doc_number] => 20220313656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => NEW CLASS OF ANTIBIOTICS HAVING LOW MIC-VALUES TOWARDS DIFFERENT STRAINS OF BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/594575
[patent_app_country] => US
[patent_app_date] => 2020-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594575
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594575 | NEW CLASS OF ANTIBIOTICS HAVING LOW MIC-VALUES TOWARDS DIFFERENT STRAINS OF BACTERIA | Apr 21, 2020 | Abandoned |
Array
(
[id] => 18620408
[patent_doc_number] => 11753436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Analogs of celastrol
[patent_app_type] => utility
[patent_app_number] => 16/849554
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 17
[patent_no_of_words] => 60187
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849554
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849554 | Analogs of celastrol | Apr 14, 2020 | Issued |
Array
(
[id] => 17756225
[patent_doc_number] => 11396509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-26
[patent_title] => Solid forms of a toll-like receptor modulator
[patent_app_type] => utility
[patent_app_number] => 16/849274
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 21
[patent_no_of_words] => 38604
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849274
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849274 | Solid forms of a toll-like receptor modulator | Apr 14, 2020 | Issued |
Array
(
[id] => 16969314
[patent_doc_number] => 11065260
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-07-20
[patent_title] => Method of treatment for reducing pulmonary inflammation in a patient with pathogen infection using oral prostacyclin analog drugs
[patent_app_type] => utility
[patent_app_number] => 16/847449
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5361
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847449
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847449 | Method of treatment for reducing pulmonary inflammation in a patient with pathogen infection using oral prostacyclin analog drugs | Apr 12, 2020 | Issued |
Array
(
[id] => 18215201
[patent_doc_number] => 11590114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumours
[patent_app_type] => utility
[patent_app_number] => 17/601487
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 11252
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601487
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601487 | Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumours | Apr 7, 2020 | Issued |